an insight into resistance mechanisms of cll cells to car-t therapy
Published 2 years ago • 127 plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
2:43
mechanisms of resistance to car-t therapy in lymphoma & potential strategies to overcome these
-
1:20
mechanisms of resistance to targeted therapies in cll
-
2:13
how changes in the gut microbiome may impact patient response to car-t therapy
-
1:29
combining ibrutinib with car-t cells: a promising therapeutic strategy in cll
-
3:38
mechanisms of resistance to car-t in all: t-cell fitness, antigen loss and immunological rejection
-
2:43
resistance mechanisms of current treatments in cll
-
3:08
resistance mechanisms in cll
-
8:43
management of st – elevation mi , time to thrombolysis, choosing and initiating reperfusion.
-
3:48
richter’s syndrome biology and cll
-
10:21
advances in car-t therapy for lymphoma
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
1:46
car-t as a next-generation therapy for cll
-
2:17
overcoming resistance to car-t therapy in cll with ibrutinib & venetoclax
-
1:53
the impact of t-cell fitness on patient response to car-t therapy
-
1:39
understanding mechanisms of resistance in myeloma
-
2:12
car-t therapy vs btk inhibitors in cll treatment
-
2:13
resistance mechanisms in cll and the importance of genomic re-testing
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
1:39
current situation of car-t therapy for cll
-
0:48
advantages of primary nk cells for the treatment of patients with hematological malignancies
-
1:22
advances in our understanding of the factors contributing to richter’s transformation in cll
-
0:56
key challenges in developing car-t therapy for cll